Eli Lilly and Company (LLY) Stock: Surges 5.95% as Q3 Revenue Jumps 39% to $24.4 Billion

TLDR Eli Lilly stock jumps 5.95% as Q3 revenue surges 39% to $24.4 billion. LLY shares gain $76.68 as Mounjaro and Zepbound drive strong quarterly growth. Eli Lilly raises 2026 revenue guidance to 91billion–92 billion after strong Q3. Eli Lilly reports $7.22 in Q3 EPS as revenue climbs and acquisition charges weigh. LLY stock rallies [...]

The post Eli Lilly and Company (LLY) Stock: Surges 5.95% as Q3 Revenue Jumps 39% to $24.4 Billion appeared first on Blockonomi.